Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts

Published:2018-07 Issue:7 Volume:29 Page:1554-1560
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lorente D.^ORCID,Olmos D.,Mateo J.,Dolling D.,Bianchini D.,Seed G.,Flohr P.,Crespo M.,Figueiredo I.,Miranda S.,Scher H.I.,Terstappen L.W.M.M.,de Bono J.S.

Funder

MRC Biomarker

Prostate Cancer UK

Experimental Cancer Medical Centre

Cancer Research UK

Department of Health

NHS

NIHR

The Institute of Cancer Research

Universidad de Valencia

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdy172/25002267/mdy172.pdf

Reference18 articles.

1. Prostate cancer;Attard;Lancet,2015

2. Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3;Scher;J Clin Oncol,2016

3. Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response;Ryan;Clin Cancer Res,2011

4. Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study;Berthold;Clin Cancer Res,2008

5. Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST;Costelloe;J Cancer,2010

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between indoor use of consumer chemical products and sleep disturbance among college students: A nationwide cross-sectional study;Building and Environment;2024-12

2. Circulating tumor cells with increasing aneuploidy predict inferior prognosis and therapeutic resistance in small cell lung cancer;Drug Resistance Updates;2024-09

3. A Role of Effector CD$$8^{+}$$ T Cells Against Circulating Tumor Cells Cloaked with Platelets: Insights from a Mathematical Model;Bulletin of Mathematical Biology;2024-06-17

4. Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients;Cells;2024-05-03

5. Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients;Molecular Oncology;2024-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3